Citigroup’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$255K	Sell	57,080 -5,935	-9%	-$27.6K	﹤0.01%	3889
2025 Q4	$347K	Buy	63,015 +29,520	+88%	+$143K	﹤0.01%	3747
2025 Q3	$110K	Sell	33,495 -96,822	-74%	-$274K	﹤0.01%	4234
2025 Q2	$301K	Sell	130,317 -2,877	-2%	-$6.25K	﹤0.01%	3872
2025 Q1	$185K	Sell	133,194 -120,098	-47%	-$201K	﹤0.01%	4248
2024 Q4	$438K	Buy	253,292 +120,680	+91%	+$250K	﹤0.01%	3923
2024 Q3	$267K	Buy	132,612 +88,677	+202%	+$195K	﹤0.01%	4148
2024 Q2	$98.4K	Sell	43,935 -211,268	-83%	-$615K	﹤0.01%	4221
2024 Q1	$732K	Sell	255,203 -55,760	-18%	-$116K	﹤0.01%	3276
2023 Q4	$550K	Buy	310,963 +29,844	+11%	+$59.5K	﹤0.01%	3336
2023 Q3	$888K	Buy	+281,119	New	+$525K	﹤0.01%	2610
2022 Q4	–	Sell	-635	Closed	-$1K	–	5959
2022 Q3	$1K	Sell	635 -523	-45%	-$1.9K	﹤0.01%	5695
2022 Q2	$4K	Sell	1,158 -9,158	-89%	-$36.3K	﹤0.01%	5718
2022 Q1	$67K	Sell	10,316 -291	-3%	-$2.17K	﹤0.01%	4608
2021 Q4	$124K	Buy	10,607 +7,286	+219%	+$110K	﹤0.01%	4624
2021 Q3	$62K	Buy	3,321 +1,950	+142%	+$37.1K	﹤0.01%	4630
2021 Q2	$29K	Buy	1,371 +795	+138%	+$18.3K	﹤0.01%	5107
2021 Q1	$12K	Sell	576 -1,038	-64%	-$28.1K	﹤0.01%	5559
2020 Q4	$43K	Buy	+1,614	New	+$34.8K	﹤0.01%	6152